HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jingfeng Wang Selected Research

fucosylated chondroitin sulfate

3/2019Anti-inflammation effects of fucosylated chondroitin sulphate from Acaudina molpadioides by altering gut microbiota in obese mice.
7/2014Fucosylated chondroitin sulfate from sea cucumber improves insulin sensitivity via activation of PI3K/PKB pathway.
11/2013Fucosylated chondroitin sulfate from Acaudina molpadioides improves hyperglycemia via activation of PKB/GLUT4 signaling in skeletal muscle of insulin resistant mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jingfeng Wang Research Topics

Disease

29Heart Failure
04/2024 - 04/2011
24Inflammation (Inflammations)
10/2023 - 08/2008
15Insulin Resistance
01/2023 - 10/2012
15Myocardial Infarction
01/2020 - 10/2009
12Neoplasms (Cancer)
02/2023 - 09/2008
12Osteoporosis
11/2022 - 11/2015
12Obesity
11/2022 - 04/2009
11Fibrosis (Cirrhosis)
07/2022 - 01/2013
10Cardiovascular Diseases (Cardiovascular Disease)
01/2023 - 11/2014
8Hypertension (High Blood Pressure)
01/2021 - 04/2009
7Infections
12/2023 - 02/2010
7Type 2 Diabetes Mellitus (MODY)
09/2023 - 12/2012
7Coronary Artery Disease (Coronary Atherosclerosis)
04/2021 - 12/2009
7Body Weight (Weight, Body)
01/2021 - 01/2013
7Infarction (Infarctions)
01/2017 - 05/2011
6Atrial Fibrillation
02/2024 - 01/2022
6Hyperglycemia
01/2023 - 07/2007
6Vascular Calcification
01/2021 - 09/2016
5COVID-19
11/2023 - 01/2021
5Hypoxia (Hypoxemia)
12/2022 - 01/2017
5Non-alcoholic Fatty Liver Disease
01/2021 - 01/2016
5Atherosclerosis
01/2020 - 08/2008
4Virus Diseases (Viral Diseases)
02/2024 - 04/2015
4Bundle-Branch Block (Fascicular Block)
11/2022 - 12/2017
4Critical Illness (Critically Ill)
01/2022 - 12/2020
4Cardiomegaly (Heart Hypertrophy)
01/2021 - 05/2014
4Lung Neoplasms (Lung Cancer)
01/2021 - 09/2008
4Fatty Liver
01/2017 - 05/2012
4Glucose Intolerance
01/2016 - 10/2012
4Malnutrition (Nutritional Deficiencies)
03/2013 - 01/2013
3Tibial Fractures (Fracture, Tibial)
12/2023 - 03/2017
3Thrombosis (Thrombus)
11/2023 - 12/2009
3Wounds and Injuries (Trauma)
10/2023 - 01/2017
3Necrosis
04/2023 - 10/2009
3Liver Cirrhosis (Hepatic Cirrhosis)
12/2022 - 11/2021
3Bone Resorption
04/2022 - 11/2015
3Human Influenza (Influenza)
01/2022 - 01/2017
3Stroke (Strokes)
01/2022 - 01/2021
3Hypertrophy
10/2021 - 05/2014
3Chronic Kidney Failure (Chronic Renal Failure)
01/2021 - 02/2013
3Chronic Renal Insufficiency
01/2021 - 01/2018
3Ventricular Remodeling
01/2015 - 10/2009
2Diabetic Cardiomyopathies
05/2024 - 12/2014
2Cardiomyopathies (Cardiomyopathy)
02/2024 - 01/2021

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
02/2024 - 04/2010
12LipidsIBA
09/2021 - 08/2008
11Glucose (Dextrose)FDA LinkGeneric
01/2023 - 10/2012
11Insulin (Novolin)FDA Link
03/2020 - 10/2012
8Peptides (Polypeptides)IBA
12/2023 - 04/2010
8Phosphatidylcholines (Phosphatidylcholine)IBA
11/2022 - 01/2017
8Sucrose (Saccharose)IBA
01/2021 - 07/2014
8CytokinesIBA
01/2021 - 03/2011
7Blood Glucose (Blood Sugar)IBA
01/2023 - 10/2012
7Biomarkers (Surrogate Marker)IBA
09/2022 - 09/2012
6CollagenIBA
07/2022 - 06/2013
6CholesterolIBA
01/2022 - 01/2013
6SialoglycoproteinsIBA
11/2021 - 02/2016
5Eicosapentaenoic AcidIBA
11/2022 - 07/2013
5Antiviral Agents (Antivirals)IBA
01/2022 - 06/2003
5Polysaccharides (Glycans)IBA
03/2021 - 07/2007
4Fatty Acids (Saturated Fatty Acids)IBA
05/2024 - 07/2013
4Triglycerides (Triacylglycerol)IBA
01/2023 - 01/2022
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2022 - 01/2017
4Docosahexaenoic AcidsIBA
11/2022 - 01/2021
4Bile Acids and Salts (Bile Acids)IBA
07/2022 - 01/2021
4Phospholipids (Phosphatides)FDA LinkGeneric
11/2021 - 07/2013
4fucoidanIBA
01/2021 - 06/2012
4C-Reactive ProteinIBA
01/2020 - 04/2009
4qiliqiangxinIBA
01/2020 - 01/2015
3Interferon Type IIBA
02/2024 - 01/2019
3Indicators and Reagents (Reagents)IBA
11/2023 - 03/2021
3Mineralocorticoid Receptor AntagonistsIBA
06/2023 - 01/2022
3DNA (Deoxyribonucleic Acid)IBA
02/2023 - 09/2008
3EpitopesIBA
01/2023 - 04/2010
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
11/2022 - 12/2015
3AntioxidantsIBA
07/2022 - 10/2015
3SaponinsIBA
04/2022 - 10/2012
3Interleukin-18 (Interleukin 18)IBA
01/2021 - 01/2015
3oxidized low density lipoproteinIBA
01/2020 - 04/2009
3fucosylated chondroitin sulfateIBA
03/2019 - 11/2013
3MicroRNAs (MicroRNA)IBA
03/2018 - 04/2012
3AcidsIBA
09/2015 - 04/2011
3AntigensIBA
01/2015 - 09/2012
2Spironolactone (Aldactone)FDA LinkGeneric
04/2024 - 06/2023
2chlorine dioxide (Alcide)IBA
11/2023 - 06/2013
2ChlorineIBA
11/2023 - 06/2013
2HydrogelsIBA
10/2023 - 12/2020
2Therapeutic UsesIBA
10/2023 - 01/2018
2omega-Chloroacetophenone (Mace)IBA
09/2023 - 01/2021

Therapy/Procedure

23Therapeutics
11/2022 - 12/2009
10Cardiac Resynchronization Therapy
11/2022 - 04/2017
8Transplantation
01/2018 - 05/2011
4Percutaneous Coronary Intervention
12/2022 - 10/2020
4Ovariectomy (Oophorectomy)
04/2022 - 06/2015
4Renal Dialysis (Hemodialysis)
03/2013 - 01/2013
3Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
02/2024 - 11/2018
3Critical Care (Surgical Intensive Care)
01/2022 - 12/2020
3Defibrillators (Defibrillator)
01/2020 - 01/2018
3Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2017 - 01/2015
2Patient Readmission
11/2023 - 01/2023